Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University Hospital, Basel, Switzerland Kantonsspital Bruderholz |
---|---|
Information provided by: | University Hospital, Basel, Switzerland |
ClinicalTrials.gov Identifier: | NCT00804063 |
Glaucoma might be a mitochondria associated disease. Since citrate is a major component in mitochondrial metabolism its determination in blood might serve as a biomarker.
Condition | Intervention |
---|---|
Glaucoma |
Procedure: drawing blood sample |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Serum Citrate in Diagnosis and Follow-up for Glaucoma |
blood, urine, serum
Estimated Enrollment: | 30 |
Study Start Date: | December 2008 |
Estimated Study Completion Date: | July 2011 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
glaucoma patients
|
Procedure: drawing blood sample
fasting blood sample
|
2
non-glaucoma controls
|
Procedure: drawing blood sample
fasting blood sample
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
tertiary university center
Inclusion Criteria:
Exclusion Criteria:
Contact: David Goldblum, MD | +41 61 2652525 | dgoldblum@uhbs.ch |
Contact: Stephan Fraenkl, MD | +41 61 2652525 | fraenkls@uhbs.ch |
Switzerland, BS | |
University Hospital Basel | Recruiting |
Basel, BS, Switzerland, 4031 | |
Contact: David Goldblum, MD +41 61 2652525 dgoldblum@uhbs.ch | |
Contact: Stephan Fraenkl, MD +41 61 2652525 fraenkls@uhbs.ch | |
Principal Investigator: David Goldblum, MD | |
Sub-Investigator: Graziella Reinhard |
Principal Investigator: | David Goldblum, MD | University Hospital Basel |
Study Chair: | Josef Flammer, MD | University Hospital Basel |
Study Director: | Selim Orguel, MD | University Hospital Basel |
Principal Investigator: | Stephan Fraenkl, MD | University Hospital Basel |
Responsible Party: | University Hospital, Basel, Switzerland ( David Goldblum, MD ) |
Study ID Numbers: | EK 325/08 |
Study First Received: | December 5, 2008 |
Last Updated: | December 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00804063 History of Changes |
Health Authority: | Switzerland: Ethikkommission; Switzerland: Laws and standards |
glaucoma citrate |
Glaucoma Eye Diseases Citric Acid Hypertension Ocular Hypertension |
Glaucoma Eye Diseases Ocular Hypertension |